Cancer Breakthrough Accidentally Discovered by Cattle Farmers?
Was the secret to beating some of today’s deadliest cancers accidentally discovered by Australian cattle farmers?
It sounds crazy… but it’s true.
You see, Big Pharma rakes in over $200 billion a year from cancer drugs alone.
And many of those drugs are tested on animals before they ever make their way to doctors and hospitals.
But 80 years ago, Australian farmers ended up conducting their own animal experiments… by mistake, on their own cows.
What they discovered seemed harmful at the time… maybe even bad luck.
But now scientists are taking a new look. And they believe that this old discovery made in Australian pastures could hold the secret to conquering some of the most difficult-to-treat cancers around.
The story seems a little hard to believe…
In the 1940s, Australian cattle farmers noticed something odd: their cows were becoming infertile after grazing on red clover.
Now, if you’re raising cattle, infertility is pretty much the last thing you want.
But scientists took a closer look… and they discovered that this humble plant contained a group of hormone-balancing compounds called isoflavones.
One of them, Biochanin A, is now catching researchers’ attention for a very different reason.
What once looked like a problem of fertility turned out to be a clue about hormones—and the power of plant compounds to help regulate them.
And now, new research suggests Biochanin A might even help the body defend itself against hormone-related cancers, such as breast, ovarian, and prostate cancers.
A 2024 Frontiers in Pharmacology review identified Biochanin A as a “multi-target isoflavone with anticancer potential.”
Researchers found that it shuts down the PI3K/Akt/mTOR and NF-κB pathways—two of the same molecular “switches” Big Pharma drugs try to control.
Another Frontiers in Oncology study showed that Biochanin A can trigger mitochondrial-driven cell death in glioblastoma (a type of brain cancer) cells—cutting off their energy supply and stopping tumor growth in its tracks.
And it doesn’t stop there.
Evidence from other lab studies shows Biochanin A may inhibit estrogen production, block new blood vessel growth, and reactivate tumor-suppressor genes—especially in breast, colon, lung, and prostate cancer models.
But here’s where it gets complicated—and important.
Biochanin A is what’s known as a phytoestrogen—a plant compound that can mildly mimic or balance estrogen in the body.
That means its effects may differ depending on the type of cancer.
In some estrogen-receptor-positive (ER+) breast cancers, it appears to block estrogen at higher doses… but at lower ones, it may act like a weak estrogen instead.
So this is one natural remedy you want to use in close consultation with your health care provider, to make sure you get the dosing right.
If you decide to explore it, look for standardized red clover or chickpea extracts containing Biochanin A (typically 20–50 mg per capsule) and talk with your doctor—especially if you have a hormone-sensitive condition.
Because one thing’s certain: the drug companies aren’t going to tell you about a natural compound that can hit the same cancer pathways their billion-dollar meds do.
And here at e-Alert, we think you deserve to know.
To truth, tenacity, and a little rebellion in your health,
Rachel Mace
Managing Editorial Director, e-Alert
with contributions from the research team
P.S. Powerful plant extract starves pancreatic cancer cells? Learn more here.
Sources:
- Sohel, M. (2024). Comprehensive exploration of Biochanin A as an oncotherapeutic potential in the treatment of multivarious cancers with molecular insights. Phytotherapy Research, 38(2), 489–506. https://pubmed.ncbi.nlm.nih.gov/37905329/
- Yu, C. (2019). Perspectives regarding the role of Biochanin A in humans: A review of mechanisms and clinical implications. Frontiers in Pharmacology. https://www.frontiersin.org/articles/10.3389/fphar.2019.00793/full
- Feng, Z. J. (2023). Chemical and biological properties of Biochanin A and its therapeutic applications. Pharmaceutics, 15(4), 1105. https://www.mdpi.com/1999-4923/15/4/1105
- Ge, W., et al. (2024). Exploring the therapeutic mechanisms and prognostic value of Biochanin A against glioblastoma: A network pharmacology analysis. Scientific Reports. https://www.nature.com/articles/s41598-024-53442-0
- Li, Y., et al. (2018). Biochanin A induces S phase arrest and apoptosis in lung cancer cells. Oxidative Medicine and Cellular Longevity. https://onlinelibrary.wiley.com/doi/10.1155/2018/3545376
- Hassan, M. H. Ul, et al. (2025). Isoflavones: Promising natural agents for cancer prevention and therapy. Food Science & Nutrition, 13(1), 456-474. https://onlinelibrary.wiley.com/doi/full/10.1002/fsn3.70091


